Advertisement
Screener

Surgery Partners, Inc. (SGRY) EBITDA

Surgery Partners, Inc. (SGRY) EBITDA

  • 2026-06-30: Basis Reported; EBITDA $141.4M; Operating income (m); Depreciation and amortization (m).
  • 2026-03-31: Basis Reported; EBITDA $104.3M; Operating income (m); Depreciation and amortization (m).
  • 2025-12-31: Basis Reported; EBITDA $170.1M; Operating income (m); Depreciation and amortization (m).
  • 2025-09-30: Basis Reported; EBITDA $145.2M; Operating income (m); Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history
2013-12-31 to 2026-06-30
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported$141.4M(m)(m)(m)16.66%$21.80M*$59.30M*(m)(m)(m)$2.60M
2026-03-31Reported$104.3M(m)(m)(m)12.86%$16.00M$11.70M(m)(m)(m)-$1.20M
2025-12-31Reported$170.1M(m)(m)(m)19.22%(m)(m)(m)(m)(m)(m)
2025-09-30Reported$145.2M(m)(m)(m)17.67%$19.80M*$83.60M*(m)(m)(m)$5.50M
2025-06-30Reported$152M(m)(m)(m)18.40%$23.40M*$81.30M*(m)(m)(m)-$1.10M
2025-03-31Reported$98.2M(m)(m)(m)12.65%$22.70M$6.00M(m)(m)(m)$0.00
2024-12-31Reported$161M(m)(m)(m)18.63%(m)(m)(m)(m)(m)(m)
2024-09-30Reported$111.1M(m)(m)(m)14.42%$20.20M*$65.20M*(m)(m)(m)$4.50M
2024-06-30Reported$119.6M(m)(m)(m)15.69%$26.90M*$82.80M*(m)(m)(m)$4.90M
2024-03-31Reported$109.7M(m)(m)(m)15.29%$21.00M$40.70M(m)(m)(m)$4.40M
2023-12-31Reported$132.5M(m)(m)(m)18.02%(m)(m)(m)(m)(m)(m)
2023-09-30Reported$111.5M(m)(m)(m)16.54%$18.90M*$104.60M*(m)(m)(m)$3.10M
2023-06-30Reported$122M(m)(m)(m)18.27%$25.80M*$52.10M*(m)(m)(m)-$7.80M
2023-03-31Reported$80.1M(m)(m)(m)12.02%$24.30M$74.50M(m)(m)(m)-$1.60M
2022-12-31Reported$123.8M(m)(m)(m)17.51%(m)(m)(m)(m)(m)(m)
2022-09-30Reported$103.9M(m)(m)(m)16.74%$17.30M*$29.70M*(m)(m)(m)$7.80M
2022-06-30Reported$104.5M(m)(m)(m)16.98%$22.40M*$42.10M*(m)(m)(m)$4.30M
2022-03-31Reported$127.8M(m)(m)(m)21.44%$18.20M$79.80M(m)(m)(m)$1.30M
2021-12-31Reported$137.5M(m)(m)(m)22.53%(m)(m)(m)(m)(m)(m)
2021-09-30Reported$88.8M(m)(m)(m)15.88%$15.50M*$14.90M*(m)(m)(m)$1.20M
2021-06-30Reported$84.7M(m)(m)(m)15.59%$13.50M*$2.30M*(m)(m)(m)-$2.70M
2021-03-31Reported$90M(m)(m)(m)17.56%$14.50M$50.20M(m)(m)(m)$200.00K
2020-12-31Reported$121.8M(m)(m)(m)22.21%(m)(m)(m)(m)(m)(m)
2020-09-30Reported$42.6M(m)(m)(m)8.59%$7.90M*$26.90M*(m)(m)(m)$1.30M
2020-06-30Reported$68.1M(m)(m)(m)18.17%$8.10M*$181.90M*(m)(m)(m)-$600.00K
2020-03-31Reported$45.3M(m)(m)(m)10.27%$11.80M$29.20M(m)(m)(m)-$15.20M
2019-12-31Reported$92M(m)(m)(m)17.79%(m)(m)(m)(m)(m)(m)
2019-09-30Reported$77.4M(m)(m)(m)17.12%$18.40M*$56.90M*(m)(m)(m)$2.40M
2019-06-30Reported$74.6M(m)(m)(m)16.75%$20.00M*$26.70M*(m)(m)(m)$1.00M
2019-03-31Reported$68.4M(m)(m)(m)16.41%$11.80M$20.50M(m)(m)(m)$1.70M
2018-12-31Reported-$33.9M(m)(m)(m)-6.90%(m)(m)(m)(m)(m)(m)
2018-09-30Reported$62M(m)(m)(m)14.34%$10.70M*$29.50M*(m)(m)(m)$5.80M
2018-06-30Reported$60.2M(m)(m)(m)13.79%$5.90M*$39.60M*(m)(m)(m)$3.30M
2018-03-31Reported$56.9M(m)(m)(m)13.83%$10.00M$30.00M(m)(m)(m)$1.80M
2017-06-30Reported$49.16M(m)(m)(m)17.05%$8.75M*$21.60M*(m)(m)(m)$512.00K
2017-03-31Reported$52.83M(m)(m)(m)18.46%$6.35M$34.87M(m)(m)(m)$2.12M
2016-12-31Reported$78.97M(m)(m)(m)25.81%(m)(m)(m)(m)(m)(m)
2016-09-30Reported$52.56M(m)(m)(m)18.59%$8.03M*$18.83M*(m)(m)(m)-$1.69M
2016-06-30Reported$60.65M(m)(m)(m)20.94%$8.55M*$48.79M*(m)(m)(m)$2.42M
2016-03-31Reported$43.85M(m)(m)(m)16.42%$11.80M$25.24M(m)(m)(m)$1.77M
2015-12-31Reported$30.14M(m)(m)(m)11.44%(m)(m)(m)(m)(m)(m)
2015-09-30Reported$52.89M(m)(m)(m)22.07%$6.57M*$29.31M*(m)(m)(m)$3.92M
2015-06-30Reported$49.47M(m)(m)(m)21.25%$6.08M*$21.47M*(m)(m)(m)$2.34M
2015-03-31Reported$46.81M(m)(m)(m)20.89%$5.46M$9.51M(m)(m)(m)$2.11M
2014-12-31Reported$2.84M(m)(m)(m)1.58%(m)(m)(m)(m)(m)(m)
2014-09-30Reported$22.49M(m)(m)(m)29.47%(m)(m)(m)(m)(m)$7.96M

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported$565.5M(m)(m)(m)17.09%$78.70M$274.30M(m)(m)(m)$18.00M
2024-12-31Reported$501.4M(m)(m)(m)16.10%$90.40M$300.10M(m)(m)(m)$134.60M
2023-12-31Reported$446.1M(m)(m)(m)16.26%$88.80M$293.80M(m)(m)(m)-$300.00K
2022-12-31Reported$460M(m)(m)(m)18.12%$80.60M$158.80M(m)(m)(m)$23.30M
2021-12-31Reported$401M(m)(m)(m)18.02%$57.60M$87.10M(m)(m)(m)$10.50M
2020-12-31Reported$277.8M(m)(m)(m)14.93%$42.90M$246.90M(m)(m)(m)-$20.10M
2019-12-31Reported$312.4M(m)(m)(m)17.06%$73.60M$129.50M(m)(m)(m)$9.50M
2018-12-31Reported$145.2M(m)(m)(m)8.20%$39.80M$144.60M(m)(m)(m)$26.40M
2016-12-31Reported$236.03M(m)(m)(m)20.61%$39.11M$125.24M(m)(m)(m)$7.09M
2015-12-31Reported$179.3M(m)(m)(m)18.68%$33.44M$84.48M(m)(m)(m)-$148.98M
2014-12-31Reported$65.87M(m)(m)(m)16.33%$7.74M$21.95M(m)(m)(m)$15.76M
2013-12-31Reported$69.89M(m)(m)(m)24.56%$4.15M$49.08M(m)(m)(m)$7.57M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Ardent Health, Inc. (ARDT)United States$1.478B17.91
COMMUNITY HEALTH SYSTEMS INC (CYH)United States$0.405B1.87
TENET HEALTHCARE CORP (THC)United States$20.097B
HCA Healthcare, Inc. (HCA)United States$93.934B15.49